February 17, 2017
2016 ANNUAL RESULTS
Media
February 16, 2017
Targovax ASA: Fourth quarter and full year 2016 results
February 13, 2017
Onxeo receives USPTO Notice of Allowance for a new AsiDNA™-related patent, expanding its IP protection in the U.S.
February 08, 2017
Information on ReLive Trial Design and Role of its Data Safety and Monitoring Board
February 08, 2017
Oncopeptides AB (publ) announces a listing of its shares on Nasdaq Stockholm
February 06, 2017
Altimmune to Present at the BIO CEO & Investor Conference
February 06, 2017
Targovax ASA: Invitation to fourth quarter and full year 2016 results presentation Thursday 16 February
February 06, 2017
Q4 2016 General Market Overview
February 02, 2017
Targovax announces encouraging top line two-year survival data from TG01 clinical trial in resected pancreatic cancer patients
February 02, 2017
Strongbridge Biopharma plc to Participate in the Canaccord Genuity Rare Disease and BioPharma One-on-One Day